MedTrace Logo

A European Post-Authorisation Observational Study (Registry) of Patients With Chronic Adrenal Insufficiency (AI)

NCT01661387 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 3258

Last updated 2024-10-15

No results posted yet for this study

Summary

As a post-approval requirement of the European Medicines Agency, this European patient post authorization safety study is an observational study being conducted to monitor the safety of long-term treatment with Plenadren and other glucocorticoid replacement therapies in routine clinical practice in patients with chronic adrenal insufficiency (primary or secondary).

Conditions

  • Chronic Adrenal Insufficiency

Sponsors & Collaborators

  • Shire

    lead INDUSTRY

Principal Investigators

  • Shire Director · Shire

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-07
Primary Completion
2020-10-31
Completion
2020-10-31

Countries

  • Germany
  • Italy
  • Netherlands
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01661387 on ClinicalTrials.gov